These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 21916843)

  • 41. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
    Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
    Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplex epigenome editing of
    Qian J; Guan X; Xie B; Xu C; Niu J; Tang X; Li CH; Colecraft HM; Jaenisch R; Liu XS
    Sci Transl Med; 2023 Jan; 15(679):eadd4666. PubMed ID: 36652535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MeCP2 deficiency is associated with impaired microtubule stability.
    Delépine C; Nectoux J; Bahi-Buisson N; Chelly J; Bienvenu T
    FEBS Lett; 2013 Jan; 587(2):245-53. PubMed ID: 23238081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
    Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rett syndrome and MeCP2.
    Liyanage VR; Rastegar M
    Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome.
    Sinnett SE; Gray SJ
    Discov Med; 2017 Oct; 24(132):153-159. PubMed ID: 29272692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of oxidative stress in Rett syndrome: an overview.
    De Felice C; Signorini C; Leoncini S; Pecorelli A; Durand T; Valacchi G; Ciccoli L; Hayek J
    Ann N Y Acad Sci; 2012 Jul; 1259():121-35. PubMed ID: 22758644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The molecular pathology of Rett syndrome: synopsis and update.
    Akbarian S; Jiang Y; Laforet G
    Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells.
    Andoh-Noda T; Inouye MO; Miyake K; Kubota T; Okano H; Akamatsu W
    CNS Neurol Disord Drug Targets; 2016; 15(5):544-50. PubMed ID: 27071793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MeCP2 Deficiency Leads to Loss of Glial Kir4.1.
    Kahanovitch U; Cuddapah VA; Pacheco NL; Holt LM; Mulkey DK; Percy AK; Olsen ML
    eNeuro; 2018; 5(1):. PubMed ID: 29464197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
    Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of aberrant NF-κB signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice.
    Kishi N; MacDonald JL; Ye J; Molyneaux BJ; Azim E; Macklis JD
    Nat Commun; 2016 Jan; 7():10520. PubMed ID: 26821816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Affective dysfunction in a mouse model of Rett syndrome: Therapeutic effects of environmental stimulation and physical activity.
    Kondo MA; Gray LJ; Pelka GJ; Leang SK; Christodoulou J; Tam PP; Hannan AJ
    Dev Neurobiol; 2016 Feb; 76(2):209-24. PubMed ID: 26019053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic analysis of the Rett syndrome experimental model mecp2
    Cortelazzo A; Pietri T; De Felice C; Leoncini S; Guerranti R; Signorini C; Timperio AM; Zolla L; Ciccoli L; Hayek J
    J Proteomics; 2017 Feb; 154():128-133. PubMed ID: 28062374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
    Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
    Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mecp2-null mice provide new neuronal targets for Rett syndrome.
    Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
    PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.
    Chapleau CA; Calfa GD; Lane MC; Albertson AJ; Larimore JL; Kudo S; Armstrong DL; Percy AK; Pozzo-Miller L
    Neurobiol Dis; 2009 Aug; 35(2):219-33. PubMed ID: 19442733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship of Rett syndrome and MECP2 disorders to autism.
    Neul JL
    Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.